Neuromedin S (NMS), a peptide structurally related to NMU, has been identified in the mammalian heart tissues. However to date, any role of NMS in cardiomyocytes and the relevant mechanisms still remain unknown. In this study, we identified a novel functional role of NMS in modulating L-type Ca 2+ channels in adult rat ventricular myocytes, in which NMU type 2 receptors (NMUR2), but not NMUR1, are endogenously expressed. We found that NMS at 0.1 µM reversibly increased I Ba by ~29.7%. Intracellular infusion of GDP-β-S or a selective antibody raised against the G i -protein blocked the stimulatory effects of NMS. The classical and novel protein kinase C (nPKC) antagonist calphostin C or chelerythrine chloride, as well as the phospholipase C (PLC) inhibitor U73122, abolished NMS responses, whereas a classical PKC antagonist Gö6976 or a PKA antagonist PKI 5-24 had no such effects. Pretreatment of cells with PKC-δ specific inhibitor rottlerin or intracellular application of a PKC-δ-derived inhibitory peptide, δV1-1, abolished NMS responses, while an inactive control peptide had no effects. In summary, NMS acting through NMUR2 increases I Ba via a G i α-protein-dependent PKC-δ pathway in rat ventricular myocytes.
Introduction
Recently, a 36 amino acid peptide related to neuromedin U (NMU) was discovered in rat brain, named neuromedin S (NMS) owning to its high expression in the spinal cord [1] . These two peptides share the same amidated C-terminal heptapeptide and bind to the same G-protein-coupled receptors, NMU type 1 (NMUR1) and type 2 (NMUR2) receptors, with NMUR2 has a greater af�inity for NMS than NMU [2] . Compared to NMU, NMS mRNA has a more limited distribution with the highest levels of expression in the hypothalamus, spleen, testis, and heart [2] [3] [4] . By activation of NMU receptors, NMS has been implicated in regulating a variety of physiological functions, including stress response, energy balance, blood pressure and heart rate modulation [5] [6] . For example, in cardiovascular system, NMS has been reported to elicit a rapid and sustained increase in blood pressure [7] . In addition, rat NMS produced a signi�icant increase in heart rate in the chronically instrumented rat model [8] . However to date, whether NMS would directly affect the function of cardiac myocytes as well as the relevant mechanisms remain still unknown.
L-type Ca 2+ channels are voltage-dependent channels that open in response to membrane depolarization to allow the entry of Ca 2+ into the cell. Ca 2+ entry through L-type Ca 2+ channels is critical in the control of cardiac function and contributes to physiological frequency regulation in the sinus node [9] [10] [11] [12] . Furthermore, L-type Ca 2+ channel is an important parameter for the duration of the plateau phase of the action potential and refractoriness, and plays a fundamental role in the process of Ca 2+ release from the sarcoplasmic reticulum, raising free intracellular Ca 2+ concentration ([Ca 2+ ] i ) and allowing cell contraction [13] . Moreover, it is clear that [Ca 2+ ] i serves as an important second messenger in the regulation of gene expression in life-threatening cardiac diseases [14] . Nonetheless, little information is available for the mechanism involved in the effect of NMS on cardiac L-type Ca 2+ channels. Therefore, the present study was undertaken to elucidate the signaling pathways implicated in cardiac L-type Ca 2+ channel modulation by NMS in adult rat ventricular myocytes, in which NMUR2, but not NMUR1, were endogenously expressed. Based on pharmacological manipulation of NMS-induced I Ba increase, we reported that NMS increased I Ba via a G i α-protein-dependent protein kinase C delta (PKC-δ) pathway.
Materials and Methods

Preparation of ventricle myocytes
All animal care and handling conformed to the Guide for Care and Use of Laboratory Animals published by the US National Institutes of Health, and the study was approved by the local institutional ethical committee. Ventricle myocytes were dissociated enzymatically by a modi�ied method described previously [15] [16] [17] . Brie�ly, Sprague-Dawley rats (male, 200-300 g) were injected intraperitoneally with 1000 IU heparin and euthanized in a CO 2 chamber. The heart was quickly removed and transferred to an ice-cold Tyrode's solution. The aorta was cannulated and the heart was mounted on a Langendorff apparatus. The heart was perfused with prewarmed (at 37°C) and oxygenated Tyrode's solution containing protease type XIV (Sigma) and collagenase type I (Sigma) for 10 min until the heart was �laccid. The ventricles were dissected out, cut into small pieces, and gently stirred in the Tyrode's solution. Isolated cells were �iltered and maintained in an oxygenated KB solution on ice. Only the cells with a rod shape and clear cross striation were used for experiments.
Reverse transcription-PCR (RT-PCR)
Total RNA was extracted from rat ventricle myocytes using the RNeasy kit (QIAGEN). Reverse transcription was carried out with SuperScript TM II (Invitrogen). Reactions without reverse transcriptase were carried out in all RT-PCRs to exclude contamination. The sequences of the primers employed in this study are summarized in Table 1 . The PCR protocol includes a denaturation step at 95 °C for 2 min, and 
Western blot
Western blot analysis was performed following the procedure described by previous reports [18] [19] [20] . For antibody detection, after incubated with 5% non-fat milk in TBST for 1 h at room temperature, membranes were then incubated with diluted primary antibody goat anti-rat NMUR1 (Santa Cruz, 1:500) or NMUR2 (Santa Cruz, 1:500) and incubated at 4 °C overnight. After 5 washes with TBST, membranes were incubated for 2 h with diluted 5000-fold donkey anti-goat secondary antibody (Sigma, USA). After 5 washes, the speci�ic binding of the primary antibody was detected with SuperSignal Ultra chemiluminescent substrate (Pierce).
Electrophysiology recording
A small aliquot of cell suspension was placed in an open perfusion chamber mounted on the stage of an inverted microscope. Myocytes were allowed to settle down to the bottom of the chamber. Only quiescent rod-shaped cells with clear striations were used. The whole-cell patch clamp experiments for recording cardiac myocytes were performed at room temperature (20-22°C). Electrodes were pulled from borosilicate glass microcapillary tubes (World Precision Instruments). They had resistances from 2 to 3 MΩ when �illed with internal solution. We made recordings using a MultiClamp 700B ampli�ier (Molecular Devices) and controlled voltage commands and digitization of membrane currents using a Digidata 1440A interfaced with Clampex 10.2 of the pClamp software package (Molecular Devices), running on a personal computer. Currents were low-pass �iltered at 2-5 kHz. Series resistance (Rs) and capacitance (Cm) values were taken directly from readings of the ampli�ier after electronic subtraction of the capacitive transients. Series resistance was compensated to the maximum extent possible (at least 70%). Current traces were corrected for linear capacitive leak with online P/6 trace subtraction.
Reagents and solutions
All drugs were obtained from Sigma (USA), unless otherwise indicated. NMS, GDP-β-S, QEHA, PKI 5-24, δV1-1 (PKC-δ inhibitor, amino acids 8-17 [SFNSYELGSL]), and the control scramble peptide were prepared in distilled deionized water. Stock solutions of U73122, U73343, chelerythrine chloride, rottlerin, Gö6976 and calphostin C were prepared in dimethyl sulfoxide (DMSO). The concentration of DMSO in the bath solution is expected to be less than 0.01%, and had no functional effects on L-type Ca 2+ channel currents (not shown). For L-type Ca 2+ channel current recordings, the external solution contained (in mM): tetraethylammonium chloride (TEA-Cl) 140, BaCl 2 
Data analysis
All data are expressed as mean±S.E.M., and GraphPad Prism 5.0 was used for electrophysiological data plotting. Student's t-tests or one-way ANOVA were used to compare the different values, and were n h ), where X is the decadic logarithm of the concentration used, IC 50 is the concentration at which the half-maximum effect occurs, and n h is the Hill coef�icient. Activation data were �itted by:
where V 1⁄2act is the potential for half-activation calculated from dual Boltzmann functions when G=0.5G max . Steady-state inactivation data were �itted by a Boltzmann function of the form: I/I max = (A1-A2)/{1+exp((V-V 1⁄2inact )/ k inact )}+A2, where I is the test-pulse current, Imax is the normalization current, A 1 is initial current amplitude, A 2 is �inal current amplitude, V is the membrane potential of the conditioning pulse, V 1/2 is the potential for half-inactivation, and k is the slope factor.
Results
Expression of NMU receptors in adult rat ventricular myocytes
To determine whether NMU receptors were endogenously expressed in rat ventricular myocytes, we characterized the mRNA and protein expression by RT-PCR and western blot, respectively. RT-PCR analysis demonstrated that NMUR2 mRNA (predicted size of speci�ic transcripts were 262 bp) were expressed in adult rat ventricular myocytes, whereas NMUR1 mRNA could not be detected (Fig. 1A) . As positive controls, NMUR1 transcripts (predicted size of 257 bp) isolated from rat lung could be clearly ampli�ied (Fig. 1A) . The negative controls performed with water or without reverse transcriptase added to the reaction yielded no detectable band. Subsequently, we investigated the protein expression of NMU receptors in rat ventricular myocytes. Western blot analysis of protein lysates using anti-NMUR2 antibody revealed that NMUR2 was expressed at the predicted size of ~47 kDa while NMUR1 was not detected by anti-NMUR1 antibody (Fig. 1B) . No band was found with goat serum (not shown). As a positive control, rat lung known to express NMUR1 showed a prominent band of ~46 kDa (Fig. 1B) . GAPDH (36 kDa) was used as the loading control.
NMS dose-dependently increases I Ba in adult rat ventricular myocytes
To test the regulation of NMS on L-type Ca 2+ channel currents, we recorded barium currents (I Ba ) from adult rat ventricular myocytes with a holding potential of -70 mV, using an external solution containing 2 mM Ba 2+ at room temperatures, to avoid Ca 2+ -dependent inactivation of Ca 2+ channels. Bath application of 0.1 µM NMS increased the basal amplitude Fig. 2A ). Upon washout of NMS, the amplitude of I Ba partially returned within 5 min (Fig. 2B) . Using the magnitude of the effect that NMS has on currents elicited by depolarization to 0 mV, it is clear that NMS increased I Ba in a concentration-dependent manner (Fig. 2C) . The relationship between the concentration of NMS used and the degree of increase observed is described by a logistic equation where the concentration of NMS producing half-maximal inhibition (IC 50 ) is 0.08 µM, the apparent Hill coef�icient is 0.91, and the maximal stimulatory effect is 37.6±2.2% (n=8, Fig. 2C ). Besides L-type Ca 2+ channel currents, we also examined whether NMS affected the voltage-gated Na + channel currents in rat ventricular myocytes. Our results showed that application of 0.1 µM NMS failed to affect Na + current density at each voltage ( Fig. 2D and E). As shown in Fig. 2E , the current-voltage (I-V) curves were not shifted, and at -20 mV the peak current densities were not signi�icantly different in the presence (130.8±8.7 pA/pF) or absence (126.1±11.2 pA/pF) of NMS (n=9, Fig. 2F ).
NMS rightward shifts steady-state inactivation curve
As a dose-dependent increase in the peak current density of I Ba was evident, we next determined whether the biophysical properties of I Ba were affected by NMS. The currentvoltage (I-V) curves showed that 0.1 µM NMS signi�icantly increased I Ba at each tested voltage, and current-voltage (I-V) plot of current density (E) of Na + current versus test voltage recorded before (n=9) and after (n=9) 0.1 µM NMS. I-V curves were obtained from a holding potential of -120 mV, 40 ms depolarizing pulses to different membrane potentials (10 mV increments from -80 mV to +40 mV). F, summary data showed that at -20 mV 0.1 µM NMS had no effects on the peak current density of Na Fig. 3 . NMS rightward shifted the steady-state inactivation curve. A-B, exemplary traces (A) and pooled data (B) showed the effects of 0.1 µM NMS on I-V curve. I-V curves were obtained from a holding potential of -70 mV, 400 ms depolarizing pulses to different membrane potentials (10 mV increments from -40 mV to +60 mV). C, the steady-state activation of L-type Ca 2+ channels is not altered by NMS application. Tail currents were elicited by repolarization to -70 mV after 40 ms test pulses from -50 to +50 mV in increments of 10 mV. D, NMS (0.1 µM) shifted steady-state inactivation curve of L-type Ca 2+ channels to depolarizing direction. I Ba evoked by 100 ms test pulse to 0 mV after the 3 s conditioning pulses ranging from -70 to 0 mV with 10 mV increments. Fig. 3C; n=9) . In contrast, NMS at 0.1 µM signi�icantly shifted the steady-state inactivation curve in the depolarizing direction by 8.6 mV (V 1/2 from −31.2±2.6 to −22.6±3.9 mV and k value from 14.7±2.1 to 15.2±3.6, Fig. 3D; n=9) , which suggest that the increase in I Ba observed upon application of NMS in rat ventricular myocytes could be due to a decreased proportion of channels remaining in the inactivated state.
NMUR2-mediated I Ba increase requires G i -protein
Previous reports have shown that NMUR2 was G i/o -protein coupled [6, 19] . To examine whether heterotrimeric G-proteins are involved in NMUR2-mediated I Ba response, we dialyzed cells with guanosine-5'-O-(2-thiodiphosphate) (GDP-β-S, 1 mM), a non-hydrolysable GDP analog, and found that intracellular application of GDP-β-S completely abolished the increase of I Ba induced by 0.1 µM NMS (increase%=2.7±1.6, n=9, Fig. 4A and D) , indicating that G-protein activation was required for NMS action. We further determined which isoform of G-protein α subunit (Gα) was involved in this increase. An antibody that speci�ically binds G i , but not G o subunit, was used to determine the subtype of G i/o involved in the NMSinduced response. Dialyzed cells with this antibody abolished the increase of NMS on I Ba (increase%=3.1±1.9, n=8, Fig. 4B and D) without signi�icantly altering the current amplitude in the absence of agonist. The boiled G i -speci�ic antibody (increase%=30.1±3.5, n=5, not shown) as well as a G o -speci�ic antibody (increase%=31.9±2.7, n=8, Fig. 4C and D) had no such effect. These results suggested that a G i -, but not G o -like protein, was involved in the NMS-induced I Ba increase.
G βγ was not involved in NMUR2-mediated I Ba increase
We next determined whether the βγ subunits of G i was involved in the NMS-mediated response. QEHA (200 µM), a synthetic peptide, which competitively binds G βγ and blocks G βγ -mediated signaling [20, 21] , was introduced into the recording pipette (Fig. 5A) . We found that intracellular application of QEHA did not affect the stimulatory effect of NMS on I Ba Fig. 5A and B) , which suggested that G i α-protein, but not its G βγ , was necessary for the NMS-induced I Ba increase. As a complementary test of our hypothesis, we also utilized a depolarizing prepulse to disrupt any potential G βγ and the L-type Ca 2+ channel interaction. No such voltage-dependent facilitation was observed in the absence or presence of NMS (Fig. 5C ). The amplitudes of I Ba evoked with and without depolarizing prepulse were measured in the absence and presence of NMS. We found that NMS (0.1 µM) induced similar I Ba incrase in the presence (increase%=29.6±3.9 with prepulse, n=11, Fig.  5D ) or absence of prepulse depolarization (29.7±3.6%, n= 9, Fig. 5D ). These results strongly suggested increase of I Ba by NMS was not through the direct interaction of G βγ subunits with L-type Ca 2+ channels in rat ventricular myocytes.
PKC-δ was involved in NMUR2-mediated I Ba increase
Since activation of NMUR2 by NMS appeared to increase I Ba via G i α-protein, we further investigated the downstream intracellular signaling molecules. Involvement of protein kinase A (PKA) in NMS-induced I Ba increase was �irst determined. We dialyzed the cells with a pipette Fig. 6A ), indicating that NMS-induced I Ba increase in rat ventricular myocytes was PKA-independent. As it has been reported that L-type Ca 2+ channels can be regulated by the PKC [22] , we investigated whether the stimulatory effects of NMS were PKC-dependent. Pretreatment of the cells with calphostin C (50 nM), a classical and novel PKC antagonist, abolished NMS-induced I Ba increase (increase%=2. 2±2.7, n=9, Fig. 6B ). Similar results were obtained with another classical and novel PKC antagonist chelerythrine chloride (increase%=2. 7±0.9, n=9, Fig. 6C ). However, pre-incubation of the cells with the classical PKC antagonist Gö6976 (1 µM) elicited no such effects (increase%=31.1±4.2, n=8, Fig. 6D ). These results together suggest that a novel PKC (nPKC) pathway might be involved in NMS-induced I Ba increase.
It has been reported that G i/o-protein activation can lead to novel PKC activation via phospholipase C (PLC) [18] . Therefore, we tested the hypothesis that PLC was necessary for NMS-induced I Ba increase. Indeed, the NMS-induced incremental effect of I Ba was abolished by the PLC inhibitor U73122 (3 µM) (increase%=2.7±3.9, n=7, Fig. 6E ). Since U73122 has been reported to have nonspeci�ic effects on various cellular events [18] , we also tested the effects of a structurally related but inactive analogue, U73343 [18] , U73343 (2 µM) had no effect on NMS-induced I Ba increase (increase%=31.6±3.9, n=7, Fig. 6F ). In astrocytes and cardiomyocytes, PLC positively modulated the phosphorylation of novel PKC delta (PKC-δ) [23] [24] [25] . We next determine the involvement of PKC-δ in NMS-induced I Ba increase. Intracellular application of a PKC-δ speci�ic inhibitor peptide, δV1-1 (1 µM), completely abolished the NMUR2-mediated I Ba increase (increase%=0. 9±1.1, n=8, Fig. 7A ). In contrast, in cells dialyzed with an inactive PKC-δ control scramble peptide (1 µM), the NMS-induced increase of I Ba was not signi�icantly affected (increase%=31. 3±2.1, n=7, Fig. 7B ). Similar results were obtained with another PKC-δ inhibitor rottlerin. As shown in Fig. 7C , pretreatment of cells with rottlerin (1 µM) abolished NMS-induced I Ba increase (increase%=1.7±2.1, n=7, Fig. 7C ). These results together indicated that NMUR2-mediated I Ba increase was via a PLCdependent PKC-δ pathway.
Discussion
Neuromedin S (NMS) and its receptors are widely expressed in brain and peripheral tissues, and possess a wide spectrum of functions [2, 6] . However, the roles of NMS in the heart remain elusive. In the present study, we �irst demonstrated that NMS plays a novel role in modulating L-type Ca 2+ channels in adult rat ventricular myocytes, whereas NMUR2, but not NMUR1, are endogenously expressed. Based on pharmacological manipulation of NMSinduced I Ba increase, we propose that this response is coupled to a G i α-protein-dependent PKC-δ pathway, which has been depicted in Fig. 8 .
Predominant studies have shown that NMUR1 was more abundant in peripheral tissues, whereas NMUR2 was located more centrally [6] . However, NMUR2 located in mouse hippocampus was also reported [26] . In addition, we show in this study that NMUR2 was expressed in adult rat ventricular myocytes, whereas NMUR1 expression could not be detected. These receptor distribution patterns have started to allow the assignment of particular physiological roles of NMS and its receptors in mammalians [6, 20, 26] . By using genetic model, previous studies have shown that activation of NMUR1 inhibited L-type Ca 2+ channel currents in mouse hippocampal neurons [26] . Interestingly, in the present study, NMS signi�icantly increased I Ba through L-type Ca 2+ channels in adult rat ventricular myocytes. The different results are not contradictory to each other, rather this may imply a distinct regulation of NMS on L-type Ca 2+ channels via distinct receptors: as NMUR1 expresses exclusively in mouse hippocampus, instead NMUR2 in rat ventricular myocytes. In addition, there are molecular and pharmacological differences between sensory neurons and cardiovascular tissue in the L-type Ca 2+ channels. In neuronal cells, the predominant pore-forming α1-subunit is Cav1.3, whereas in cardiac muscle cells, the principal α1-subunit is Cav1.2 [27, 28] .
It has been previously suggested that G i/o α could interact directly with Ca 2+ channels [18, 29] . However, such a mechanism is not likely in our system because we observed that inhibition of PLC or novel PKC completely abolished the effect of NMS on I Ba . We also found that G βγ did not seem to directly interact with the Ca 2+ channels because NMS-induced I Ba increase was neither accompanied by slow activation kinetics of the I Ba nor removed by a depolarizing pre-pulse. Furthermore, pipette application of peptides which disrupt interactions between G βγ subunits and Ca 2+ channels did not affect NMUR2-mediated I Ba increase. The apparent independence of G βγ subunits in the modulation of L-type Ca 2+ channels may indicate that rat ventricular myocytes express a Ca 2+ channel that is insensitive to the G βγ subunits of G iprotein binding. An alternative hypothesis is that different Cav1.2 channel splice variants are able to generate different L-type Ca 2+ channel functions [10] . For example, alternative splicing of the Cav1.2 channel changes the sensitivity of L-type Ca 2+ channel to dihydropyridines [30] . In addition, it is still possible that NMS-mediated NMUR2 activation does not result in currents recorded from isolated cardiomyocytes were shown to be increased by glucagonlike peptide-1 via the cAMP-PKA-dependent pathway [34] . By contrast, L-type Ca 2+ current inhibition by CB1 cannabinoid receptor activation in GT1-7 hypothalamic neurons was prevented by application of PKA inhibitors [35] . Similarly, Cav1.2 current inhibition by integrin receptor activation was blocked by addition of PKA inhibitor H89 [36] . In the present study, we found that the inhibitory effect of NMS on I Ba was independent of PKA, which suggests that some other mechanisms, but not cAMP/PKA pathway, are involved in the stimulatory effect of NMS. Our data showed that PKC-δ was involved in NMS-induced I Ba increase because: 1) pretreatment of cells with classic and novel PKC inhibitors, but not the classic PKC inhibitor, could completely abolish the increase of NMS on I Ba ; 2) the PKC-δ inhibitor rottlerin or intracellular application of a PKC-δ-derived inhibitory peptide, δV1-1, but not its inactive analogue abolished the NMS-induced I Ba increase. Our present results were supported by previous studies that activation of novel PKC increases I Ba in neonatal hippocampus [37] . It has also been shown that PKC phosphorylates Cav1.2b α1C Ca 2+ channel subunit, which results in up-regulation of the L-type Ca 2+ currents [38] . Similar results were reported in rat portal vein myocytes [39] . However, PKC-induced L-type Ca 2+ current inhibition was also described. For example, in mouse hippocampal neurons, activation of PKC inhibits L-type Ca 2+ channel currents while an inactive analogue has no effect [26] . This could be explained by a distinct PKC phosphorylation site or different regulation of L-type Ca 2+ channel subunits (Ca V 1.2 and Ca V 1.3) in different tissues/cell types [33] . An alternative hypothesis is that PKC phosphorylates an intermediate protein that in turn up-regulates the L-type Ca 2+ channels. In summary, this study presents a novel action of NMS on L-type Ca 2+ channel currents in adult rat ventricular myocytes, in which NMUR2, but not NMUR1 was endogenously expressed. NMS signi�icantly increased L-type Ca 2+ channel currents via stimulation of NMUR2. We provide evidence for a second messenger pathway initiated by NMUR2 that couples sequentially to the G i α-protein and downstream PKC-δ, which is involved in NMSinduced L-type Ca 2+ channel stimulation. Whether the same signaling pathway exists in human hearts and the resulting physiological functions requires further investigations in large mammals such as non-human primates.
